<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04097171</url>
  </required_header>
  <id_info>
    <org_study_id>CT2019MS3</org_study_id>
    <nct_id>NCT04097171</nct_id>
  </id_info>
  <brief_title>The Effect of Diet Composition on Performance, Expenditure, Blood Lipids, and Appetite Hormones in Highly Trained Cyclists</brief_title>
  <acronym>DCAP</acronym>
  <official_title>The Effect of Diet Composition on Performance, Energy Expenditure, Blood Lipids and Lipoproteins, and Cognitive Function and Mood States in Highly Trained Cyclists</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Texas Christian University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Texas Christian University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study employs a crossover design to evaluate the effect of two different diets (high
      carbohydrate vs. ketogenic) and corresponding test meals on endurance exercise performance,
      energy expenditure including resting metabolic rate and thermic effect of food, postprandial
      responses of blood lipids, glucose and appetite hormones, and cognitive function and mood
      states.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Traditionally, a high carbohydrate diet is recommended for elite endurance athletes and
      sub-elite, highly trained recreational athletes competing in endurance events. However,
      recently the ketogenic diet (extremely low carbohydrate content) has become popular in these
      populations. The effect on endurance exercise performance, energy expenditure, postprandial
      blood profiles, and cognitive function and mood states requires further investigation.

      In this study, highly trained recreational cyclists and triathletes will adhere to each diet
      (high-carbohydrate and ketogenic) for 14 days in a crossover design. Experimental trials at
      baseline and after each diet will evaluate endurance cycling performance (time trial),
      resting energy expenditure, the thermic effect of food of test meals corresponding in
      composition to each diet, postprandial responses of blood lipids, glucose and appetite
      hormones, and cognitive function and mood states.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 11, 2019</start_date>
  <completion_date type="Anticipated">March 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endurance Cycling Performance</measure>
    <time_frame>180 min after the meal begins</time_frame>
    <description>Time to completion in a 30-kilometer simulated time trial</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Respiratory Exchange Ratio</measure>
    <time_frame>Change from baseline at 30 min, 60 min, 90 min, 120 min, 150 min, 180 min, 192 min, 204 min, 216 min, 228 min and 240 min after the meal begins</time_frame>
    <description>Indirect calorimetry fasted, postprandial, and during exercise</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle Fuel Rating</measure>
    <time_frame>Change from baseline at 180 min and 240 min after the meal begins</time_frame>
    <description>Ultrasound echogenicity of Rectus Femoris</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen consumption (VO2)</measure>
    <time_frame>At 192 min, 204 min, 216 min, 228 min and 240 min after the meal begins</time_frame>
    <description>Indirect calorimetry during exercise</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rating of Perceived Exertion (RPE)</measure>
    <time_frame>At 192 min, 204 min, 216 min, 228 min and 240 min after the meal begins</time_frame>
    <description>6-20 Borg's scale during exercise</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thermic Effect of Food (postprandial energy expenditure)</measure>
    <time_frame>Change from baseline at 30 min, 60 min, 90 min, 120 min, 150 min, 180 min after the meal begins</time_frame>
    <description>Fasted vs. postprandial indirect calorimetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective appetite ratings</measure>
    <time_frame>Change from baseline at 60 min, 120 min, 180 min after the meal begins</time_frame>
    <description>Visual Analog Scale (Scale 1: Perception of Hunger [0-100 mm]; Scale 2: Perception of Fullness [0-100 mm]; Scale 3: Desire to Eat [0-100 mm]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Appetite hormones including ghrelin, leptin, insulin, and Peptide-YY</measure>
    <time_frame>Change from baseline at 30 min, 60 min, 120 min, 180 min and 240 min</time_frame>
    <description>Fasted, postprandial &amp; post exercise blood concentration of appetite hormones</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood glucose</measure>
    <time_frame>Change from baseline at 180 min and 240 min after the meal begins; on day 7 of each diet</time_frame>
    <description>Fasted, postprandial &amp; post exercise blood concentration of glucose</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>Change from baseline at 180 min after the meal begins</time_frame>
    <description>Fasted, postprandial &amp; post exercise</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive function</measure>
    <time_frame>At 180 min and 240 min after the meal begins</time_frame>
    <description>Stroop test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mood state questionnaire</measure>
    <time_frame>At 180 min and 240 min after the meal begins</time_frame>
    <description>Abbreviated Profile of Mood States; 40-item scale; Likert scale from 0 = &quot;not at all&quot; to 4 = &quot;extremely&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resting Metabolic Rate</measure>
    <time_frame>At baseline before meal begins</time_frame>
    <description>Indirect calorimetry in fasted state</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood lipids including (triglycerides, total cholesterol, low density lipoprotein, and high-density lipoprotein)</measure>
    <time_frame>Change from baseline at 30 min, 60 min, 120 min, 180 min, 192 min, 204 min, 216 min, 228 min and 240 min after the meal begins</time_frame>
    <description>Fasted and postprandial in mg/dL</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Endurance Cycling Performance</condition>
  <arm_group>
    <arm_group_label>High Carbohydrate Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will consume a high carbohydrate diet (65-75% of total energy intake). Protein intake will be standardized at 15% of total energy intake.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketogenic Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will consume a low carbohydrate diet (&lt;5-10% of total energy intake). Protein intake will be standardized at 15% of total energy intake.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Diet</intervention_name>
    <description>Participants will consume each diet for 14 days in a crossover design.</description>
    <arm_group_label>High Carbohydrate Diet</arm_group_label>
    <arm_group_label>Ketogenic Diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt;100-150km of cycling per week

          -  VO2max &gt; 80th percentile for sex and age (adjusted for cycle ergometry)

          -  apparently healthy

        Exclusion Criteria:

          -  weight loss supplements/medications/diet

          -  extreme dietary patterns (e.g. extremely high or low carbohydrate)

          -  nicotine use

          -  heavy alcohol use (&gt;7 drinks/week female; &gt;14 drinks/week male)

          -  food allergies

          -  diabetes

          -  heart disease

          -  stroke

          -  liver/kidney/thyroid disease

          -  anemia

          -  eating disorders

          -  uncontrolled hypertension

          -  pulmonary/orthopedic/musculoskeletal problems that prevent exercise

          -  surgery that affects swallowing and digestion

          -  claustrophobia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Meena Shah, PhD</last_name>
    <phone>817-257-6871</phone>
    <email>m.shah@tcu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Andreas Kreutzer</last_name>
    <phone>817-257-6859</phone>
    <email>a.kreutzer@tcu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Texas Christian University</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76129</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meena Shah, Ph.D.</last_name>
      <email>m.shah@tcu.edu</email>
    </contact>
    <investigator>
      <last_name>Meena Shah, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>September 17, 2019</study_first_submitted>
  <study_first_submitted_qc>September 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 20, 2019</study_first_posted>
  <last_update_submitted>April 25, 2020</last_update_submitted>
  <last_update_submitted_qc>April 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Texas Christian University</investigator_affiliation>
    <investigator_full_name>Meena Shah</investigator_full_name>
    <investigator_title>Interim Chair, Professor and Director, Graduate Program</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De-identified study data of all outcome variables will be shared on an Open Science Framework project page (osf.io) along with the study protocol, statistical analysis plan, and analytic code</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Will become available at the latest June 2021 and be available indefinitely</ipd_time_frame>
    <ipd_access_criteria>Openly available</ipd_access_criteria>
    <ipd_url>http://osf.io/ujx6e/</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

